Thromboses sur cathéter central chez le patient cancéreux

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Revue de Médecine Interne

• Publication date

  2007-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.REVMED.2007.03.002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial.

  2006cited by this paper
• Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer.

  2005cited by this paper
• Meta-Analysis: The Value of Clinical Assessment in the Diagnosis of Deep Venous Thrombosis

  2005cited by this paper
• The prognostic significance of the ball-valve effect in Groshong catheters

  2005cited by this paper
• Le guide du bon usage des examens d’imagerie médicale par J. Grellet

  2005cited by this paper
• Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

  2005cited by this paper
• Thrombose symptomatique sur cathéter veineux central de longue durée en oncologie : un score de risque prédictif?

  2005cited by this paper
• Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis.

  2005cited by this paper
• Upper-Extremity Deep Vein Thrombosis: A Prospective Registry of 592 Patients

  2004cited by this paper
• Long-term central venous access.

  2004cited by this paper
• Factor V Leiden and G20210A prothrombin mutation and the risk of subclavian vein thrombosis in patients with breast cancer and a central venous catheter.

  2004cited by this paper
• Thrombotic complications of central venous catheters in cancer patients.

  2004cited by this paper
• Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis.

  2004cited by this paper
• American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.

  2003cited by this paper
• Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.

  2003cited by this paper
• Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler‐ultrasound

  2003cited by this paper
• American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.

  2003cited by this paper
• Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.

  2003cited by this paper
• Minidose warfarin is associated with a high incidence of International Normalized Ratio elevation during chemotherapy with FOLFOX regimen.

  2003cited by this paper
• Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial.

  2003cited by this paper
• An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.

  2003cited by this paper
• Minidose warfarin prophylaxis for catheter-associated thrombosis in cancer patients: can it be safely associated with fluorouracil-based chemotherapy?

  2003cited by this paper
• Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and Characteristics

  2002cited by this paper
• Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

  2002cited by this paper
• Prospective Study of Color Duplex Ultrasonography Compared with Contrast Venography in Patients Suspected of Having Deep Venous Thrombosis of the Upper Extremities

  2002cited by this paper
• Factor V Leiden in central venous catheter‐associated thrombosis

  2002cited by this paper
• Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review.

  2002cited by this paper
• Comparison of Venography and Ultrasound for the Diagnosis of Asymptomatic Deep Vein Thrombosis in the Upper Body in Children

  2002cited by this paper
• Complications of central venous catheters: Internal jugular versus subclavian access—A systematic review

  2002cited by this paper
• Magnetic resonance venography in assessing venous patency after multiple venous catheters.

  2002cited by this paper
• A randomized, prospective trial of central venous ports connected to standard open‐ended or Groshong catheters in adult oncology patients

  2001cited by this paper
• [Spiral x-ray computed tomography in the diagnosis of central venous catheterization complications].

  2001cited by this paper
• Catheter-related Upper Extremity Deep Venous Thrombosis in Cancer Patients: A Prospective Study Based on Doppler US

  2001cited by this paper
• Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study.

  2000cited by this paper
• Longterm central venous access in gynecologic cancer patients.

  2000cited by this paper
• Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors.

  2000cited by this paper
• Prospective randomized comparison of valved versus nonvalved peripherally inserted central vein catheters.

  1999cited by this paper
• Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion.

  1999cited by this paper
• Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data.

  1999cited by this paper
• Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters

  1999cited by this paper
• Outpatient Use of Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis of the Upper Extremity

  1999cited by this paper
• Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials.

  1998cited by this paper
• Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies

  1998cited by this paper
• Factor V leiden mutation does not account for central venous catheter‐related thrombosis

  1998cited by this paper
• Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study.

  1997cited by this paper
• Thrombin Activity Associated with Indwelling Central Venous Catheters

  1997cited by this paper
• A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancy.

  1997cited by this paper
• Normal saline versus heparin flush for maintaining central venous catheter patency during apheresis collection of peripheral blood stem cells (PBSC).

  1997cited by this paper
• Upper-extremity deep vein thrombosis.

  1997cited by this paper
• Complications of long arm-catheters: a randomized trial of central vs peripheral tip location.

  1996cited by this paper
• Supraventricular tachycardia precipitated by a peripherally inserted central catheter.

  1996cited by this paper
• [Experimental prevention of deep venous thrombosis with low-molecular-weight heparin using implantable infusion devices].

  1996cited by this paper
• MR angiography for mapping potential central venous access sites in patients with advanced venous occlusive disease.

  1996cited by this paper
• Upper Extremity Deep Venous Thrombosis in Cancer Patients with Venous Access Devices - Prophylaxis with a Low Molecular Weight Heparin (Fragmin)

  1996cited by this paper
• Clinical Investigations: MiscellaneousMagnetic Resonance Angiography of the Central Chest Veins: A New Gold Standard?

  1995cited by this paper
• Complications of indwelling venous access devices in cancer patients.

  1995cited by this paper
• Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients.

  1995cited by this paper
• The diagnostic value of colour Doppler ultrasound in central venous catheter related thrombosis.

  1995cited by this paper
• Central venous catheter practices: results of a survey.

  1995cited by this paper
• The relationship between the thrombotic and infectious complications of central venous catheters.

  1994cited by this paper
• Complications and failures of subclavian-vein catheterization.

  1994cited by this paper
• Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports

  1993cited by this paper
• Ultrasound‐Assisted Cannulation of the Internal Jugular Vein A Prospective Comparison to the External Landmark‐Guided Technique

  1993cited by this paper
• Preoperative duplex venous imaging in the assessment of patients with venous access

  1993cited by this paper
• Groshong catheter-associated subclavian venous thrombosis.

  1993cited by this paper
• Limitations of magnetic resonance imaging and ultrasound-directed (duplex) scanning in the diagnosis of subclavian vein thrombosis.

  1991cited by this paper
• Utility of duplex ultrasound in the diagnosis of asymptomatic catheter‐induced subclavian vein thrombosis.

  1991cited by this paper
• Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study.

  1991cited by this paper
• Comparison of colour Doppler ultrasound with venography in the diagnosis of axillary and subclavian vein thrombosis.

  1991cited by this paper
• Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial.

  1990cited by this paper
• Color Doppler sonographic imaging in the assessment of upper-extremity deep venous thrombosis.

  1990cited by this paper
• Hickman catheter‐induced thoracic vein thrombosis. Frequency and long‐term sequelae in patients receiving high‐dose chemotherapy and marrow transplantation

  1990cited by this paper
• Source and route of microbial colonisation of parenteral nutrition catheters.

  1989cited by this paper
• Where antecubital catheters go: a study under fluoroscopic control

  1989cited by this paper
• Internal jugular and subclavian vein thrombosis caused by central venous catheters. Evaluation using Doppler blood flow imaging.

  1988cited by this paper
• Thrombosis of upper extremity thoracic inlet veins: diagnosis with duplex Doppler sonography.

  1987cited by this paper
• Prevention of thrombosis of central venous catheters.

  1986cited by this paper
• Autopsy findings after prolonged catheterization of the right atrium for chemotherapy in acute leukemia.

  1985cited by this paper
• Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial.

  1983cited by this paper
• Diagnosis of upper extremity deep venous thrombosis using noninvasive technique.

  1982cited by this paper
• Diagnosis of Thrombosis by Catheter Phlebography after Prolonged Central Venous Ca theterization

  1981cited by this paper
• A modified right atrial catheter for access to the venous system in marrow transplant recipients.

  1979cited by this paper
• Letter: Early breast cancer and postoperative irradiation.

  1975cited by this paper
• A silicone rubber atrial catheter for prolonged parenteral alimentation.

  1973cited by this paper
• Letter: S.S.P.E. and Salk vaccine.

  1973cited by this paper
• Subclavian Vein Catheterizations: A Prospective Study I. Non‐Infectious Complications

  1971cited by this paper

• [Technical criteria of central venous catheters: Anaesthesiologist/intensivist and pharmacist opinions].

  2015cites this paper
• Complications thromboemboliques sur cathéters centraux de longue durée en onco-hématologie pédiatrique

  2015cites this paper
• Pose de chambre implantable par abord percutané échoguidé : à propos d’une série de 102 patients

  2013cites this paper
• A complication of port-a-cath: disconnection and migration of central venous catheter to pulmonary artery. A case report.

  2012cites this paper
• Chapitre 1 – Pathologie Veineuse Aiguë: Anatomie des Veines Profondes

  2011cites this paper
• Chapitre 25 – Cancer et Vaisseaux

  2011cites this paper
• [Percutaneous implantable port-related infection and thrombosis: diagnostic and management].

  2011cites this paper
• Les thromboses veineuses profondes des membres supérieurs

  2011cites this paper
• A prospective 7-year survey on central venous catheter-related complications at a single pediatric hospital

  2009cites this paper
• Étude de prévention de la thrombose veineuse associée au cathéter veineux central de type PICC chez les patients en oncologie recevant une chimiothérapie

  2009cites this paper
• [Venous thromboembolism associated with long-term use of central venous catheters in cancer patients].

  2008cites this paper